Adient Capital Allocation and China Business Update

Segment Performance ADIENT Q1 2022 Q1 2023 Americas EMEA AP Corporate/ Eliminations Corporate/ Consolidated Americas EMEA AP Consolidated Eliminations Net Sales 1,498 1,230 784 (32) 3,480 1,724 1,182 821 (28) 3,699 Adjusted EBITDA 9 43 114 (20) 146 69 28 138 (23) 212 Adjusted Equity Income (1) (1) 36 34 1 3 23 27 Depreciation 31 31 13 75 34 25 10 69 Capex 23 24 13 60 60 37 14 10 61 Q2 2022 Q2 2023 Corporate/ Americas EMEA AP Consolidated Americas EMEA AP Eliminations Corporate/ Eliminations Consolidated Net Sales 1,596 1,218 723 (31) 3,506 1,761 1,401 774 Adjusted EBITDA 46 30 105 (22) 159 72 53 113 (24) (23) 3,912 215 Adjusted Equity Income 1 16 17 1 3 8 12 Depreciation 32 31 13 76 32 27 12 71 Capex 27 18 12 57 26 19 11 56 YTD 2022 YTD 2023 Corporate/ Americas EMEA AP Consolidated Americas EMEA AP Eliminations Corporate/ Eliminations Consolidated Net Sales 3,094 2,448 1,507 Adjusted EBITDA 55 73 219 (63) (42) 6,986 3,485 2,583 1,595 (52) 7,611 305 141 81 251 (46) 427 Adjusted Equity Income (1) 52 51 2 6 31 39 Depreciation Capex 63 62 26 151 66 52 22 140 50 42 25 117 63 33 21 117 J.P. Morgan China Investor Meeting Adient PUBLIC 38

View entire presentation